Literature DB >> 2901685

The ionic mechanisms underlying opioid actions.

I McFadzean1.   

Abstract

Recent experiments using intracellular recording techniques in vitro have revealed that common ionic mechanisms may explain the actions of opioid drugs. Evidence is now available from studies on guinea pig gut myenteric and submucous plexi, from preparations of spinal cord and dorsal root ganglia, from brain slices including the locus coeruleus and from neuroblastoma/glioma hybrid cells. The concensus is that mu opioid receptors activate an outward potassium conductance, possibly by way of adenylate cyclase. Activation of the receptor increases the membrane permeability to potassium ions and thus produces a membrane hyperpolarisation and conductance increase, plus an indirect inhibition of calcium entry during the action potential. Kappa opioids appear to inhibit directly the entry of calcium through voltage-dependent calcium channels, although to date there is no conclusive evidence that this mechanism of action can be extended to neurones of the central nervous system. The mechanism of action of delta opioids has only recently been investigated and initial evidence suggests they increase a potassium conductance similar to that increased by mu opioids. However, work in neuroblastoma x glioma hybrid cells has suggested that in these cells at least, receptor activation depress a component of voltage-dependent calcium current. The link between the receptor and the calcium channel involves a G-protein, Go.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901685     DOI: 10.1016/0143-4179(88)90072-8

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  13 in total

1.  Effect of opioid peptides on circular muscle of canine duodenum.

Authors:  A J Bauer; J H Szurszewski
Journal:  J Physiol       Date:  1991-03       Impact factor: 5.182

Review 2.  Calcium channels in cellular membranes.

Authors:  P G Kostyuk
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

3.  Regulation of neural responses in the canine pyloric sphincter by opioids.

Authors:  O Bayguinov; K M Sanders
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

Review 4.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  mu-Opioid and delta-opioid receptors are expressed in brainstem antinociceptive circuits: studies using immunocytochemistry and retrograde tract-tracing.

Authors:  A E Kalyuzhny; U Arvidsson; W Wu; M W Wessendorf
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.

Authors:  Pei-Lan Zhou; Yu-Lei Li; Ling-Di Yan; Zheng Yong; Gang Yu; Hua-Jin Dong; Hui Yan; Rui-Bin Su; Ze-Hui Gong
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

7.  Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro.

Authors:  M Capogna; B H Gähwiler; S M Thompson
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

8.  Effects of epidural fentanyl on speed and quality of block for emergency cesarean section in extending continuous epidural labor analgesia using ropivacaine and fentanyl.

Authors:  Jeong-Yeon Hong; Young Seok Jee; Hyeong Jun Jeong; Young Song; Hae Keum Kil
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

9.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.

Authors:  Mary-Ann Greco; Patrick M Fuller; Thomas C Jhou; S Martin-Schild; James E Zadina; Zhian Hu; Priyattam Shiromani; Jun Lu
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.